Company Isodiol International Inc. Canadian Securities Exchange
Equities
ISOL
CA46500L2003
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Nutritional Health Products
100.0
%
| 19 | 100.0 % | 22 | 100.0 % | +16.26% |
Sales per region
CAD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 19 | 100.0 % | 22 | 100.0 % | +16.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 17-05-23 |
Director/Board Member | - | 18-08-29 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 19-02-13 |
Dianne Szigety
SEC | Corporate Secretary | 69 | 17-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 17-05-23 |
Director/Board Member | - | 18-08-29 | |
Director/Board Member | - | 18-11-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 98,334,359 | 98,334,359 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.18B | |
+3.98% | 3.16B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |